Trade Fresenius SE & Co KGaA - FRE CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.10 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.024161% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.020283% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 20% | ||||||||
Stock exchange | Germany | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Fresenius SE & Co KGaA ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 27.25 |
Open* | 26.76 |
1-Year Change* | -26.85% |
Day's Range* | 26.66 - 27.12 |
52 wk Range | 19.69-38.11 |
Average Volume (10 days) | 1.22M |
Average Volume (3 months) | 26.88M |
Market Cap | 15.27B |
P/E Ratio | 9.40 |
Shares Outstanding | 563.24M |
Revenue | 40.16B |
EPS | 2.88 |
Dividend (Yield %) | 3.39358 |
Beta | 1.07 |
Next Earnings Date | Feb 23, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 27.01 | 0.15 | 0.56% | 26.86 | 27.14 | 26.62 |
Feb 2, 2023 | 27.25 | 0.70 | 2.64% | 26.55 | 27.28 | 26.55 |
Feb 1, 2023 | 26.56 | 0.02 | 0.08% | 26.54 | 26.67 | 26.36 |
Jan 31, 2023 | 26.48 | -0.16 | -0.60% | 26.64 | 26.68 | 26.33 |
Jan 30, 2023 | 26.74 | 0.19 | 0.72% | 26.55 | 26.80 | 26.31 |
Jan 27, 2023 | 26.70 | 0.51 | 1.95% | 26.19 | 26.79 | 26.15 |
Jan 26, 2023 | 26.30 | -0.38 | -1.42% | 26.68 | 26.80 | 26.11 |
Jan 25, 2023 | 26.89 | -0.48 | -1.75% | 27.37 | 27.47 | 26.76 |
Jan 24, 2023 | 27.71 | -0.33 | -1.18% | 28.04 | 28.07 | 27.53 |
Jan 23, 2023 | 28.12 | -0.33 | -1.16% | 28.45 | 28.47 | 27.84 |
Jan 20, 2023 | 28.25 | 0.21 | 0.75% | 28.04 | 28.29 | 27.93 |
Jan 19, 2023 | 27.99 | -0.19 | -0.67% | 28.18 | 28.30 | 27.66 |
Jan 18, 2023 | 28.34 | -0.24 | -0.84% | 28.58 | 28.71 | 28.15 |
Jan 17, 2023 | 28.49 | 0.06 | 0.21% | 28.43 | 28.73 | 28.17 |
Jan 16, 2023 | 28.61 | 0.17 | 0.60% | 28.44 | 28.67 | 28.35 |
Jan 13, 2023 | 28.25 | 0.04 | 0.14% | 28.21 | 28.48 | 27.97 |
Jan 12, 2023 | 28.23 | 0.02 | 0.07% | 28.21 | 28.84 | 27.96 |
Jan 11, 2023 | 27.98 | 0.57 | 2.08% | 27.41 | 28.23 | 27.31 |
Jan 10, 2023 | 27.49 | -0.55 | -1.96% | 28.04 | 28.12 | 27.35 |
Jan 9, 2023 | 28.28 | -0.05 | -0.18% | 28.33 | 28.66 | 28.20 |
Fresenius SE & Co KGaA Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 29471 | 33886 | 33530 | 35409 | 36277 | 37520 |
Revenue | 29471 | 33886 | 33530 | 35409 | 36277 | 37520 |
Cost of Revenue, Total | 19958 | 23395 | 23696 | 25061 | 25961 | 27209 |
Gross Profit | 9513 | 10491 | 9834 | 10348 | 10316 | 10311 |
Total Operating Expense | 25169 | 29297 | 28279 | 30778 | 31892 | 33362 |
Selling/General/Admin. Expenses, Total | 4853 | 5554 | 4873 | 5406 | 5430 | 5453 |
Research & Development | 486 | 543 | 650 | 603 | 724 | 762 |
Depreciation / Amortization | 16 | 15 | 16 | 17 | 20 | 22 |
Unusual Expense (Income) | 26 | -26 | -802 | -4 | -24 | 21 |
Other Operating Expenses, Total | -170 | -184 | -154 | -305 | -219 | -105 |
Operating Income | 4302 | 4589 | 5251 | 4631 | 4385 | 4158 |
Interest Income (Expense), Net Non-Operating | -582 | -667 | -587 | -719 | -659 | -506 |
Net Income Before Taxes | 3720 | 3922 | 4664 | 3912 | 3726 | 3652 |
Net Income After Taxes | 2676 | 3033 | 3714 | 3029 | 2823 | 2819 |
Minority Interest | -1116 | -1219 | -1687 | -1146 | -1116 | -1001 |
Net Income Before Extra. Items | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
Net Income | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
Income Available to Common Excl. Extra. Items | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
Income Available to Common Incl. Extra. Items | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
Diluted Net Income | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
Diluted Weighted Average Shares | 550.085 | 557.507 | 557.305 | 557.417 | 557.744 | 558.156 |
Diluted EPS Excluding Extraordinary Items | 2.83593 | 3.25377 | 3.63715 | 3.37808 | 3.06054 | 3.25715 |
Dividends per Share - Common Stock Primary Issue | 0.62 | 0.75 | 0.8 | 0.84 | 0.88 | 0.92 |
Diluted Normalized EPS | 2.95754 | 3.552 | 2.65123 | 3.5531 | 3.34581 | 2.6265 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 8984 | 9246 | 9324 | 9966 | 9720 |
Revenue | 8984 | 9246 | 9324 | 9966 | 9720 |
Cost of Revenue, Total | 6526 | 6628 | 6801 | 7254 | 7162 |
Gross Profit | 2458 | 2618 | 2523 | 2712 | 2558 |
Total Operating Expense | 7978 | 8225 | 8316 | 8843 | 8818 |
Selling/General/Admin. Expenses, Total | 1266 | 1400 | 1300 | 1487 | 1488 |
Research & Development | 181 | 186 | 198 | 197 | 174 |
Depreciation / Amortization | 5 | 5 | 6 | 6 | 5 |
Operating Income | 1006 | 1021 | 1008 | 1123 | 902 |
Interest Income (Expense), Net Non-Operating | -137 | -121 | -126 | -122 | -118 |
Net Income Before Taxes | 869 | 900 | 882 | 1001 | 784 |
Net Income After Taxes | 671 | 708 | 681 | 759 | 599 |
Minority Interest | -236 | -237 | -268 | -260 | -186 |
Net Income Before Extra. Items | 435 | 471 | 413 | 499 | 413 |
Net Income | 435 | 471 | 413 | 499 | 413 |
Income Available to Common Excl. Extra. Items | 435 | 471 | 413 | 499 | 413 |
Income Available to Common Incl. Extra. Items | 435 | 471 | 413 | 499 | 413 |
Diluted Net Income | 435 | 471 | 413 | 499 | 413 |
Diluted Weighted Average Shares | 557.649 | 560.714 | 558.108 | 558.487 | 558.502 |
Diluted EPS Excluding Extraordinary Items | 0.78006 | 0.84 | 0.74 | 0.89349 | 0.73948 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0.92 | 0 |
Diluted Normalized EPS | 0.46297 | 0.59729 | 0.77459 | 0.67626 | 0.53715 |
Unusual Expense (Income) | 6 | 11 | 4 | ||
Other Operating Expenses, Total | -105 | ||||
Interest Expense (Income) - Net Operating | -11 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 11744 | 12604 | 14790 | 15264 | 15772 | 17461 |
Cash and Short Term Investments | 1769 | 1462 | 2586 | 1543 | 1716 | 931 |
Cash | 1215 | 956 | 1150 | 1047 | 1071 | |
Cash & Equivalents | 303 | 497 | 1436 | 496 | 645 | 931 |
Short Term Investments | 251 | 9 | ||||
Total Receivables, Net | 6051 | 7206 | 7766 | 8972 | 8695 | 9308 |
Accounts Receivable - Trade, Net | 5311 | 6288 | 6628 | 7880 | 7411 | 7532 |
Total Inventory | 3189 | 3252 | 3218 | 3633 | 3945 | 4218 |
Prepaid Expenses | 113 | 121 | 147 | 273 | 459 | 441 |
Other Current Assets, Total | 622 | 563 | 1073 | 843 | 957 | 2563 |
Total Assets | 46697 | 53133 | 56703 | 67006 | 66646 | 71962 |
Property/Plant/Equipment, Total - Net | 8139 | 9555 | 10366 | 17266 | 17603 | 18583 |
Property/Plant/Equipment, Total - Gross | 15401 | 17172 | 18881 | 27566 | 29156 | 32271 |
Accumulated Depreciation, Total | -7262 | -7617 | -8515 | -10300 | -11553 | -13688 |
Goodwill, Net | 22901 | 25285 | 25713 | 27737 | 26599 | 28943 |
Intangibles, Net | 1763 | 3172 | 3130 | 3869 | 3736 | 3831 |
Long Term Investments | 256 | 19 | ||||
Note Receivable - Long Term | 460 | 555 | 723 | 220 | 132 | |
Other Long Term Assets, Total | 1434 | 1943 | 1981 | 2650 | 2804 | 3144 |
Total Current Liabilities | 9079 | 10665 | 13275 | 13884 | 13216 | 15062 |
Accounts Payable | 1315 | 1688 | 1823 | 1905 | 1816 | 2039 |
Accrued Expenses | 3030 | 2912 | 3298 | 1056 | 915 | 1150 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 2475 | 245 | 2841 |
Current Port. of LT Debt/Capital Leases | 2059 | 3017 | 5094 | 3033 | 3425 | 1931 |
Other Current Liabilities, Total | 2675 | 3048 | 3060 | 5415 | 6815 | 7101 |
Total Liabilities | 34033 | 39472 | 41292 | 50228 | 49697 | 52964 |
Total Long Term Debt | 12843 | 16143 | 14040 | 21750 | 22243 | 22383 |
Long Term Debt | 12697 | 15909 | 13821 | 16104 | 16821 | 16625 |
Capital Lease Obligations | 146 | 234 | 219 | 5646 | 5422 | 5758 |
Deferred Income Tax | 935 | 1110 | 1284 | 1418 | 1390 | 1515 |
Minority Interest | 8185 | 8059 | 9597 | 9802 | 9074 | 10290 |
Other Liabilities, Total | 2991 | 3495 | 3096 | 3374 | 3774 | 3714 |
Total Equity | 12664 | 13661 | 15411 | 16778 | 16949 | 18998 |
Common Stock | 547 | 555 | 556 | 557 | 557 | 558 |
Retained Earnings (Accumulated Deficit) | 11544 | 13504 | 15185 | 16411 | 17527 | 18886 |
Other Equity, Total | 573 | -398 | -330 | -190 | -1135 | -446 |
Total Liabilities & Shareholders’ Equity | 46697 | 53133 | 56703 | 67006 | 66646 | 71962 |
Total Common Shares Outstanding | 547.208 | 554.71 | 556.225 | 557.38 | 551.853 | 558.502 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 16693 | 16901 | 17334 | 17461 | 18002 |
Cash and Short Term Investments | 1877 | 2250 | 2413 | 931 | 2077 |
Cash & Equivalents | 1877 | 2250 | 2413 | 931 | 2077 |
Total Receivables, Net | 7776 | 7497 | 7553 | 7192 | 7983 |
Accounts Receivable - Trade, Net | 7596 | 7369 | 7402 | 7045 | 7794 |
Total Inventory | 4092 | 4197 | 4257 | 4218 | 4423 |
Other Current Assets, Total | 2948 | 2957 | 3111 | 5120 | 3519 |
Total Assets | 68966 | 69655 | 71081 | 71962 | 73114 |
Property/Plant/Equipment, Total - Net | 17914 | 17940 | 18126 | 18583 | 18643 |
Goodwill, Net | 27523 | 27675 | 28338 | 28943 | 29373 |
Intangibles, Net | 3752 | 3754 | 3771 | 3831 | 3836 |
Other Long Term Assets, Total | 3084 | 3385 | 3512 | 3144 | 3260 |
Total Current Liabilities | 15947 | 15204 | 15352 | 15062 | 14138 |
Accounts Payable | 1635 | 1669 | 1649 | 2039 | 1897 |
Notes Payable/Short Term Debt | 2037 | 2738 | 2472 | 2841 | 2652 |
Current Port. of LT Debt/Capital Leases | 4079 | 2536 | 2577 | 1931 | 1282 |
Other Current Liabilities, Total | 8196 | 8261 | 8654 | 8251 | 8307 |
Total Liabilities | 51159 | 51956 | 52780 | 52964 | 53244 |
Total Long Term Debt | 20392 | 22015 | 22142 | 22383 | 23277 |
Long Term Debt | 14812 | 16470 | 16554 | 16625 | 17543 |
Capital Lease Obligations | 5580 | 5545 | 5588 | 5758 | 5734 |
Deferred Income Tax | 1526 | 1750 | 1800 | 1515 | 1650 |
Minority Interest | 9707 | 9432 | 9885 | 10290 | 10714 |
Other Liabilities, Total | 3587 | 3555 | 3601 | 3714 | 3465 |
Total Equity | 17807 | 17699 | 18301 | 18998 | 19870 |
Common Stock | 557 | 558 | 558 | 558 | 558 |
Retained Earnings (Accumulated Deficit) | 17961 | 17948 | 18376 | 18886 | 19313 |
Other Equity, Total | -711 | -807 | -633 | -446 | -1 |
Total Liabilities & Shareholders’ Equity | 68966 | 69655 | 71081 | 71962 | 73114 |
Total Common Shares Outstanding | 557.542 | 558.041 | 558.454 | 558.502 | 558.502 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | 2676 | 3033 | 3714 | 3029 | 2823 | 2819 |
Cash From Operating Activities | 3585 | 3937 | 3742 | 4263 | 6549 | 5078 |
Cash From Operating Activities | 982 | 1139 | 1133 | 2085 | 2715 | 2667 |
Amortization | 233 | 298 | 362 | 327 | ||
Deferred Taxes | 3 | -230 | 100 | 71 | 43 | 84 |
Non-Cash Items | 2 | -122 | -876 | -67 | -60 | 42 |
Cash Taxes Paid | 894 | 1187 | 918 | 773 | 765 | 750 |
Cash Interest Paid | 562 | 566 | 519 | 733 | 627 | 517 |
Changes in Working Capital | -311 | -181 | -691 | -1182 | 1028 | -534 |
Cash From Investing Activities | -2101 | -7570 | -1464 | -4856 | -3011 | -2817 |
Capital Expenditures | -1641 | -1823 | -2149 | -2459 | -2406 | -2047 |
Other Investing Cash Flow Items, Total | -460 | -5747 | 685 | -2397 | -605 | -770 |
Cash From Financing Activities | -974 | 3872 | -1273 | -484 | -3117 | -1452 |
Financing Cash Flow Items | 116 | 157 | -290 | 381 | -980 | -601 |
Total Cash Dividends Paid | -738 | -924 | -904 | -952 | -468 | -491 |
Issuance (Retirement) of Stock, Net | 78 | 23 | 55 | -551 | -348 | 38 |
Issuance (Retirement) of Debt, Net | -430 | 4616 | -134 | 638 | -1321 | -398 |
Foreign Exchange Effects | 25 | -182 | 68 | 22 | -238 | 118 |
Net Change in Cash | 535 | 57 | 1073 | -1055 | 183 | 927 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 671 | 1379 | 2060 | 2819 | 599 |
Cash From Operating Activities | 652 | 2103 | 3329 | 5078 | 101 |
Cash From Operating Activities | 622 | 1263 | 1922 | 2667 | 693 |
Deferred Taxes | -24 | -38 | -34 | 84 | -22 |
Non-Cash Items | -8 | -4 | -26 | 42 | -11 |
Cash Taxes Paid | 83 | 428 | 552 | 750 | 87 |
Cash Interest Paid | 143 | 256 | 377 | 517 | 158 |
Changes in Working Capital | -609 | -497 | -593 | -534 | -1158 |
Cash From Investing Activities | -474 | -1429 | -1986 | -2817 | -448 |
Capital Expenditures | -417 | -924 | -1371 | -2047 | -362 |
Other Investing Cash Flow Items, Total | -57 | -505 | -615 | -770 | -86 |
Cash From Financing Activities | -184 | -328 | -895 | -1452 | -375 |
Financing Cash Flow Items | -50 | -434 | -511 | -601 | 470 |
Total Cash Dividends Paid | 0 | -491 | -491 | -491 | 0 |
Issuance (Retirement) of Stock, Net | 1 | 21 | 36 | 38 | 1 |
Issuance (Retirement) of Debt, Net | -135 | 576 | 71 | -398 | -846 |
Foreign Exchange Effects | 46 | 67 | 128 | 118 | 35 |
Net Change in Cash | 40 | 413 | 576 | 927 | -687 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Else Kroner-Fresenius Foundation | Corporation | 26.96 | 151848770 | 0 | 2022-11-23 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.74 | 26697447 | 0 | 2022-11-23 | LOW |
Harris Associates L.P. | Investment Advisor/Hedge Fund | 3.02 | 17009766 | 0 | 2022-07-07 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 2.98 | 16784471 | 189035 | 2022-07-07 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.1356 | 12028619 | 33229 | 2022-12-31 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 2.11 | 11884186 | 533930 | 2022-12-31 | HIGH |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.5399 | 8673403 | 314431 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.5039 | 8470403 | -755472 | 2022-12-31 | LOW |
Franklin Mutual Advisers, LLC | Investment Advisor/Hedge Fund | 1.1631 | 6551075 | 4448 | 2022-12-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 1.1567 | 6514879 | -11045 | 2022-12-31 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 0.6428 | 3620496 | 115247 | 2022-12-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.5374 | 3026773 | -22435 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.5309 | 2990424 | 27106 | 2022-12-31 | LOW |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.5187 | 2921254 | -45468 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4935 | 2779757 | 0 | 2023-01-31 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 0.4468 | 2516717 | -24863 | 2022-12-31 | LOW |
Caixabank Asset Management SGIIC, S.A.U. | Investment Advisor | 0.4093 | 2305529 | 0 | 2022-11-30 | MED |
Tweedy, Browne Company LLC | Investment Advisor | 0.4039 | 2275130 | -652500 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.3902 | 2197748 | -22543 | 2022-12-31 | LOW |
Swedbank Robur Fonder AB | Investment Advisor/Hedge Fund | 0.3775 | 2126132 | -6968 | 2022-12-31 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Fresenius SE & Co Company profile
About Fresenius SE & Co KGaA
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Fresenius SE & Co KGaA revenues increased 3% to EUR37.52B. Net income increased 7% to EUR1.82B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from EUR3.06 to EUR3.26.
Equity composition
11/2005, Rights Issue, 2 new shares for every 9 shares held @ EUR 93 (Factor: 1.025064). 02/2007, Complex capital change (Factor: 3). 07/2007, Company name changed from Fresenius AG. 8/2014, Scrip Issue, 2 new share for every 1 share held (Factor: 3).
Industry: | Hospitals, Clinics & Primary Care Services |
Else-Kröner-Str. 1
BAD HOMBURG VOR DER HOHE
HESSEN 61352
DE
Income Statement
- Annual
- Quarterly
News

S&P 500 & DAX 40 Forecast for the Week Ahead
S&P 500 builds higher after Fed meeting, DAX 40 runs into resistance
16:30, 3 February 2023
FX Weekly Outlook: USD, GBP/USD, USD/JPY Analysis
USD, GBP/USD, USD/JPY forecasts for the week ahead.
15:56, 3 February 2023
GBP/USD drops below 1.23 as BOE comments suggest possible end of rate hikes
Despite increasing rates by 50bps at their February meeting, the messaging from the BOE suggests a dovish tilt an the possible end of rate hikes.
15:37, 2 February 2023
Gold latest: XAU/USD rallies on Fed meeting as traders eye Friday’s jobs data
Gold buyers take advantage of risk on sentiment as they eye Friday's NFP data to assess the likelihood of a soft landing
11:48, 2 February 2023
British Pound (GBP) Outlook: GBP/USD, EUR/GBP Ahead of BoE Rate Decision
Bank of England remains a dovish hiker. GBP at risk of another dovish twist
15:13, 1 February 2023People also watch
Still looking for a broker you can trust?
Join the 480.000+ traders worldwide that chose to trade with Capital.com